small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 33 results

Practice Area

International Arbitration

Winston has decades of experience representing clients in international arbitrations around the world. Representing clients in both commercial and investor-state international arbitrations, we are well known by the leading players in the global arbitration arena. Our integrated team of attorneys enforces awards worldwide, knows every angle of international disputes, and has a robust understanding of our client’s industries....Read more

Practice Area

Litigation/Trials

Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial....Read more

Region

Latin America & Caribbean

Winston’s deep experience representing companies and investors across Latin America and the Caribbean has made the firm a “go-to” resource for the strategic development of our clients’ businesses and the vigorous protection of their interests in the region. With broad command of a diverse range of issues within the region’s key industry sectors, we advise Fortune 500 companies, government and quasi-governmental entities, financial institutions, private equity and other investors, domestic and international oil and gas exploration and production companies, refiners and shippers, and a range of commercial and infrastructure developers....Read more

Experience 23 results

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Winston & Strawn represented Revere Securities LLC acted as the lead placement agent in connection with PicoCELA, Inc. in the closing of its public offering of 6,100,000 American Depositary Shares ("ADSs") at a public placement price of $0.30 per ADS. PicoCELA, Inc. received an aggregate gross proceeds of $1.83 million before deducting placement agent commission and other offering expenses. Each ADS represents one common share of the Company....Read more

Experience

|

April 30, 2025

Rapid Ruling: Fifth Circuit Affirms Winston Win on Summary Judgment the Day After Oral Argument

Winston recently secured a total victory for our clients, KVP Energy Services, LLC and other affiliated defendants, at the U.S. Court of Appeals for the Fifth Circuit. Plaintiff BHI Energy I Power Services LLC filed suit in the U.S. Northern District of Texas in September 2022, alleging US$150M in damages in connection with causes of action for misappropriation of trade secrets, unfair competition, and various other business torts and statutory violations. Winston scored an important early win in January 2023 by defeating BHI Energy’s motion for preliminary injunction. After a year of extensive discovery, Winston moved for full summary judgment on behalf of all defendants. In a strongly worded opinion, the district court granted Winston’s summary judgment motion and dismissed the entirety of BHI’s lawsuit....Read more

Experience

|

November 13, 2024

Winston advised Astorg on the acquisition of a majority stake in Redslim, in partnership with its founders and management team

Winston and Strawn Paris represented Astorg, a leading Pan-European private equity firm in connection with the  signing of a binding agreement to acquire a majority stake in Redslim (the “Company”) from its Founders, Eric Bensimon, Alberto Alcaniz, Soren Altmann and Patric Mezei (the “Founders”), who will re-invest significantly in the business. Redslim provides data management services, leveraging a proprietary technology platform, and focusing on Consumer-Packaged Goods (CPG) and Consumer Healthcare (CHC) segments. Through this partnership, Astorg will support the Company’s growth and international expansion, collaborating closely with the Founders and the management team. ...Read more
View All Experience

Insights & News 1,085 results

Press Release

|

October 13, 2025

|

2 Min Read

Winston & Strawn Relocates Chicago Office to 300 North LaSalle

CHICAGO – October 13, 2025 – Winston & Strawn LLP announced today that it has relocated its Chicago office to 300 North LaSalle, a landmark riverfront tower....Read more

Sponsorship

|

October 9, 2025

Winston & Strawn Sponsors the 45th Annual Ray Garrett Jr. Corporate & Securities Law Institute

Winston & Strawn is proud to sponsor the 45th Annual Ray Garrett Jr. Corporate & Securities Law Institute at the Northwestern Pritzker School of Law in Chicago, IL....Read more

Client Alert

|

September 23, 2025

|

2 Min Read

FinCEN Issues Proposed Rule to Delay the Investment Adviser AML Rule by Two Years

Last month, we published an alert about the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) order providing exemptive relief for covered investment advisers from certain anti-money laundering and combating the financing of terrorism  program and other Bank Secrecy Act-related reporting, recordkeeping and information-sharing obligations (IA AML Rule) until January 1, 2028. The IA AML Rule, published by FinCEN as a final rule on September 4, 2024, is currently set to become effective on January 1, 2026. 
On September 22, 2025, FinCEN published a notice of proposed rulemaking to amend the IA AML Rule to delay its effective date by two years, from January 1, 2026 to January 1, 2028.

View All Insights & News

Other Results 25 results

Site Content

In Memoriam:
David A. Coulson

Site Content

The Corporate Transparency Act
Task Force

Law Glossary

What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?

There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising